Search Trials
Conditions
Learn
About

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula as an Adjunct to Atorvastatin in the Treatment of Hemorrhagic Moyamoya Disease. | MicrobiomeTrials

← Back to trials

NCT07894640

Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula as an Adjunct to Atorvastatin in the Treatment of Hemorrhagic Moyamoya Disease.

ENROLLING_BY_INVITATIONEARLY_PHASE1INTERVENTIONAL

Trial Details

Start: 2024-12-31Est. Completion: 2027-01-31

Enrollment target: 60 participants

Locations

Jiangsu Province Hospital (Jiangsu Provincial People's Hospital), Nanjing, Jiangsu, China

Other microbiome trials you might be interested in

Prospective Observational Cohort Study for Predicting Unruptured Intracranial Aneurysm Rupture Risk Using Blood Pressure Variability and 3D Structural EvolutionRecruiting

Unruptured Intracranial AneurysmIntracranial Aneurysm Rupture

This is a single-center, prospective, longitudinal observational cohort study in adults with unruptured intracranial ane…

Beijing, ChinaEst. completion Dec 31, 2037

View Trial →

Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya SyndromeRecruiting

Moyamoya DiseaseMoyamoya Syndrome

This multicenter prospective observational cohort study aims to develop and validate individualized risk prediction mode…

Beijing, ChinaEst. completion Feb 28, 2030

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.